{"sourcedb":"DevicePMAs@therightstef","sourceid":"P140025_S000","text":"Approval for the ventana alk (d5f3) cdx assay. this device is indicated for the following: ventana alk (d5f3) cdx assay is intended for the qualitative detection of the anaplastic lymphoma kinase (alk) protein in formalin-fixed, paraffin-embedded (ffpe) non-small cell lung carcinoma (nsclc) tissue stained with a benchmark xt automated staining instrument. it is indicated as an aid in identifying patients eligible for treatment with xalkori (crizotinib).","project":"consensus_PMA_Age_Indications"}